|
Jul 22
|
U.S. Biomarkers Market Forecast 2025-2034 Featuring Analysis of Roche, Merck, Thermo Fisher Scientific, QIAGEN and Other Industry Leaders
|
|
Jul 22
|
Roche Canada announces Polivy® (polatuzumab vedotin for injection) for the First-Line Treatment of Adults With Large B-Cell Lymphoma is now Publicly Reimbursed in Québec
|
|
Jul 22
|
Avant Technologies' Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference
|
|
Jul 22
|
Replimune drug rejected by FDA; Omega raises $647M biotech fund
|
|
Jul 22
|
Mixed results from Roche’s mAb in COPD
|
|
Jul 22
|
Bispecific Antibodies Market Set to Surge to $163.15 Billion by 2032, Driven by a Robust 40.1% CAGR | Roche, Amgen, and Johnson & Johnson at the Forefront: AnalystView Market Insights
|
|
Jul 21
|
AstraZeneca Plans to Invest $50 Billion in U.S. by 2030
|
|
Jul 21
|
SRPT Down After Third Death in Muscular Dystrophy Gene Therapy Program
|
|
Jul 21
|
Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm
|
|
Jul 21
|
India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher
|
|
Jul 21
|
Cote d'Ivoire IVD Market Forecast Report 2025-2032 | Opportunities in Public-Private Partnerships, Molecular Diagnostics Demand, Telemedicine and Point-of-Care Testing
|
|
Jul 18
|
Genentech Provides Update on Supplemental Biologics License Application for Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
|
|
Jul 18
|
Regeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold?
|
|
Jul 18
|
Is Europe losing the AI race? Magnificent Seven widen gap over Europe's giants
|
|
Jul 18
|
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche
|
|
Jul 17
|
Recursion Pharmaceuticals Rises 6% in a Month: How to Play the Stock
|
|
Jul 17
|
SRPT Stock Soars on Unveiling New Restructuring Plan, Pipeline Pivots
|
|
Jul 17
|
Novartis Beats on Q2 Earnings and Sales, CFO Retires, Stock Down
|
|
Jul 17
|
Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships
|
|
Jul 16
|
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
|